Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haploidentical Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05622032
What this trial is testing

Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Laurent Kaiser 52
Early research (Phase 1)Study completedNCT02660281
What this trial is testing

URMC Related Haplo-identical Donor BMT

Who this might be right for
Hematological DiseaseImmune DeficienciesSolid Tumors+3 more
University of Rochester 74
Testing effectiveness (Phase 2)Looking for participantsNCT03173937
What this trial is testing

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Who this might be right for
Severe Aplastic AnemiaHypo-Plastic MDSMyelodysplastic Syndrome (MDS)
National Heart, Lung, and Blood Institute (NHLBI) 37
Early research (Phase 1)WithdrawnNCT04579523
What this trial is testing

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Who this might be right for
Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01050946
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Lymphocytic, ChronicLeukemia, Myelocytic, Acute+3 more
Medical College of Wisconsin 1
Early research (Phase 1)Looking for participantsNCT05066412
What this trial is testing

Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

Who this might be right for
Hematologic MalignancyHaplo-identical Stem Cell Transplantation
University Hospital, Geneva 12
Testing effectiveness (Phase 2)Looking for participantsNCT06564545
What this trial is testing

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Zhengzhou University 276
Early research (Phase 1)Looking for participantsNCT04678401
What this trial is testing

IS-free Treg HaploHCT

Who this might be right for
Stem Cell Transplant ComplicationsGraft Vs Host DiseaseMyeloid Leukemia, Acute+2 more
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT01220544
What this trial is testing

Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells

Who this might be right for
Acute Myeloid LeukemiasAdvanced Hematological MalignanciesIndication for Allogeneic Stem Cell Transplantation+1 more
Charite University, Berlin, Germany 30
Post-approval studies (Phase 4)UnknownNCT05914675
What this trial is testing

Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT

Who this might be right for
The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
Institute of Hematology & Blood Diseases Hospital, China 21
Not applicableStudy completedNCT02193880
What this trial is testing

Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)

Who this might be right for
Hematologic NeoplasmsGraft-Versus-Host Disease
Ayman Saad 7
Testing effectiveness (Phase 2)Study completedNCT04942730
What this trial is testing

Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)

Who this might be right for
Leukemia, Acute LymphoblasticMyeloid Leukemia, AcuteBiphenotypic Acute Leukemia+3 more
St. Petersburg State Pavlov Medical University 50
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Not applicableUnknownNCT02643589
What this trial is testing

Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 200
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Testing effectiveness (Phase 2)Study completedNCT00604201
What this trial is testing

Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)Severe Aplastic Anemia (SAA)
National Heart, Lung, and Blood Institute (NHLBI) 31
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Large-scale testing (Phase 3)UnknownNCT06525519
What this trial is testing

Comparison of Different Dose of Anti-T Lymphocyte Globulin (ATLG) in Haploidentical HSCT for GVHD Prophylaxis

Who this might be right for
Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 104
Testing effectiveness (Phase 2)Study completedNCT04503616
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

Who this might be right for
Graft-versus-host Disease
NYU Langone Health 46
Large-scale testing (Phase 3)Ended earlyNCT03699475
What this trial is testing

Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Bellicum Pharmaceuticals 1
Next Page